Home > Healthcare > Medical Devices > Diagnostic Devices > Fundus Cameras Market
Non-mydriatic fundus cameras market accounted for around 58% of revenue share in 2022 and is expected to witness notable demand from 2023-2032. Non-mydriatic fundus cameras provide retinal imaging without requiring pupil dilation to offer enhanced patient-friendly and time-efficient advantages. These cameras have grown in popularity in clinical settings as well as distant teleophthalmology services for more extensive access to retinal screening. The increasing use of these devices in eye care facilities as well as the higher emphasis on preventative eye health will drive the market expansion.
Fundus cameras market from the ophthalmology clinics segment amassed substantial revenue in 2022 and is estimated to reach over USD 494 million by 2032. Ophthalmology diagnostics clinics are increasingly adopting fundus cameras to offer non-invasive and efficient retinal imaging capabilities. These devices enable early detection and monitoring of various eye conditions, including diabetic retinopathy, glaucoma, and macular degeneration, enhancing patient care and treatment outcomes. The rising prevalence of eye diseases coupled with the growing technological advancements will also fuel the market growth.
North America fundus cameras market generated more than USD 260 million in revenue in 2022 and may acquire dominant share by 2032. The well-established healthcare infrastructure and the high frequency of age-related eye issues in the region are contributing to the market growth. According to CDC 2022 estimates, roughly 12 million individuals aged 40 and above in the U.S. suffer vision impairment. Rising advances in ophthalmic technology as well as the strong existence of prominent manufacturers investing in significant R&D efforts will also boost the regional market outlook.